Results 141 to 150 of about 6,273,650 (192)

Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study [PDF]

, 2005
Murray, CDR, Martin, NM, Bloom, SR, Ghatei, MA, Kamm, MA, Patterson, M, Johnston, C, Emmanuel, AV, Taylor, SA   +8 more
core  

Meta-inflammation through the lens of macrophage programming and nutrient-sensing ghrelin signaling. [PDF]

Immunometabolism (Cobham)
Han HW, Kim DM, Eshghjoo S, Xu C, Liu Z, Patil BS, Guo S, Sun Y.   +7 more
europepmc   +1 more source

Long-acting growth hormone therapy in paediatric growth hormone deficiency: reduced treatment burden and unproven motivation-related neuroendocrine effects. [PDF]

Front Endocrinol (Lausanne)
Gaudino R, Antoniazzi F, Zaffanello M, Pietrobelli A, Zoller T, Lanzafame R, Piacentini G.   +6 more
europepmc   +1 more source

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. [PDF]

Front Endocrinol (Lausanne)
Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M.   +5 more
europepmc   +1 more source

Spontaneous Splenic Rupture in a Patient With Recent Use of Performance-Enhancing Compounds: A Case Report and Literature Review. [PDF]

Cureus
Jaffry K, Shah J, Naqash N.
europepmc   +1 more source

Structurally distinct polysaccharides differentially affect laying performance, hepatic lipid metabolism, intestinal endocrine markers, cecal microbial and metabolic profiles in aged laying hens. [PDF]

Poult Sci
Wang M, Amevor FK, Cao X, Li X, Yue X, Lyu X, Jiao H, Wang X, Zhao J, Li H, Liu M, Lin H.   +11 more
europepmc   +1 more source

Differential somatostatin sensitivity of corticotropic and somatotropic responses following amino acid infusion. [PDF]

Endocr Connect
Sturlaugsson Jóhönnuson EM, Reiche J, Richter MM, Wewer Albrechtsen NJ.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Growth hormone secretagogue receptor antagonists

Expert Opinion on Therapeutic Patents, 2012
The patent claims peptidic/nonpeptidic inhibitors of the ghrelin receptor, the growth hormone secretagogue receptor (GHSR) 1A. Among these compounds, it was disclosed that the addition in some compounds of a GlyMetAla tripeptide at the N-terminus of the ghrelin peptide agonists converts them into ghrelin receptor antagonists.
Luca Costantino
exaly   +4 more sources

A relationship between motilin and growth hormone secretagogue receptors

Regulatory Peptides, 2012
The motilin receptor (MR) belongs to a family of Class I G protein-coupled receptors that also includes growth hormone secretagogue receptor (GHSR). Their potentially unique structure and the molecular basis of their binding and activation are not yet clear.
Bunzō Matsuura, Teru Kumagi, Teruki Miyake   +2 more
exaly   +3 more sources

Growth Hormone–Releasing Hormone and Growth Hormone Secretagogue-Receptor Ligands

Endocrine, 2001
Growth hormone-releasing hormone (GHRH) and somatostatin are the most important hypothalamic neurohormones controlling growth hormone (GH) secretion. Several neurotransmitters and neuropeptides also play an important role in the control of GH secretion, mainly acting via modulation of GHRH and somatostatin. In the past two decades, particular attention
Emanuela Arvat, Laura Gianotti, Roberta Giordano, Fabio Broglio, Mauro Maccario, Fabio Lanfranco, Giampiero Muccioli, Mauro Papotti, Andrea Graziani, Ezio Ghigo, Romano Deghenghi   +10 more
openaire   +5 more sources